Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Microchannel Device Measures Blood Viscosity

By HospiMedica International staff writers
Posted on 21 Sep 2017
An innovative optical device can measure blood viscosity at the point of care, providing an early warning sign of a potential cardiovascular event.

Developed by researchers at the University of Connecticut (UConn; Storrs, USA), the whole blood rheometer measures blood viscosity by extrapolation of the time it takes blood to travel through a disposable transparent microchannel card. More...
To perform the test, a droplet of blood is placed on the card; blood then wicks into the microchannel under capillary pressure. The microchannel card is then placed between a light source and a photodiode detector, with the velocity of the wicking blood converted into a viscosity reading that indicates elevated risk for cardiac events.

Once the test is completed, the used microchannel card is discarded and replaced with a new one. Since the device itself never comes in contact with the biological sample, practitioners don’t need to sterilize it in between patients or worry about cross-contamination. According to the researchers, current blood viscosity tests involve a mechanical rheometer, which requires large samples, takes much longer, and needs to be sterilized between tests. In addition, the travel time between the medical office and the test facility means that samples are often no longer reliable.

“We were very surprised that there is no commercial option to quickly and simply check this critical piece of information,” said George Lykotrafitis, PhD, an associate professor of mechanical engineering and co-inventor of the device. “The research shows there is a connection between blood viscosity and cardiac events, and the equipment exists to test it, but not in a practical or efficient way. We decided to try to solve the problem.”

“Our technology really is plug-and-play, but the impact is significant. With this information, doctors can suggest simple life-style changes on the spot to prevent their patients from having a stroke or heart attack,” concluded co-inventor Kostyantyn Partola, MSc, who added that they are in early discussions with physicians at UConn Health and Yale University School of Medicine (Yale; New Haven, CT, USA) to conduct clinical trials.

Blood behaves as a non-Newtonian fluid (a fluid that does not follow Newton's Law of Viscosity). In a Newtonian fluid, the relation between the shear stress and the shear rate is linear, with the constant of proportionality being the coefficient of viscosity. In a non-Newtonian fluid, the relationship between shear stress and shear rate shifts, and a constant coefficient of viscosity cannot be defined. Since the velocity of blood differs when pumping and at rest, it’s viscosity also changes. Other examples of non-Newtonian fluids include paint, ketchup, toothpaste, starch suspensions, and shampoo.

Related Links:
University of Connecticut
Yale University School of Medicine

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.